Medicare Enrolled
Dr. Benny Wang, MD
Neurology · Conroe, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Benny Wang is a neurology in Conroe, TX, with 19 years in practice. Based on federal Medicare data, Dr. Wang performed 15,830 Medicare services across 1,512 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wang received a total of $46,941 from 94 pharmaceutical and/or device companies across 1551 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 5% volume in TX$ $46,941 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,830
Medicare services
Top 5% in TX for neurology
1,512
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~833 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 13,700 | $5 | $25 |
| Office visit, established patient (30-39 min) | 508 | $84 | $237 |
| Office visit, established patient, complex (40-54 min) | 375 | $123 | $319 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 274 | $74 | $201 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 257 | $191 | $523 |
| Nerve conduction, 13 or more studies | 137 | $214 | $669 |
| New patient office visit, complex (60-74 min) | 133 | $156 | $455 |
| EEG, extended monitoring | 112 | $326 | $909 |
| New patient office visit (45-59 min) | 70 | $118 | $361 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 64 | $25 | $65 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | 60 | $813 | $6,000 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 60 | $159 | $440 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 31 | $108 | $321 |
| Electronic analysis of implanted neurostimulator generator with complex cranial nerve stimulator programming | 29 | $35 | $120 |
| Measurement of brain wave activity (eeg), continuous | 20 | $203 | $1,295 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$46,941
Total received (2018-2024)
Avg $6,706/year across 7 years
Top 10% in TX for neurology
94
Companies
1,551
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,956 (59.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,984 (40.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,270
2023$4,712
2022$6,439
2021$9,375
2020$14,144
2019$3,486
2018$3,514
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$11,657
AbbVie Inc.
$5,728
ABBVIE INC.
$2,487
Novartis Pharmaceuticals Corporation
$2,003
Teva Pharmaceuticals USA, Inc.
$1,424
EMD Serono, Inc.
$1,232
JAZZ PHARMACEUTICALS INC.
$1,132
Biogen, Inc.
$1,102
Lundbeck LLC
$1,044
Genentech USA, Inc.
$926
UCB, Inc.
$925
Sunovion Pharmaceuticals Inc.
$899
Neurocrine Biosciences, Inc.
$818
Takeda Pharmaceuticals U.S.A., Inc.
$756
Eisai Inc.
$736
CSL Behring
$700
ACADIA Pharmaceuticals Inc
$658
Medtronic, Inc.
$652
Lilly USA, LLC
$583
US WorldMeds, LLC
$558
ARGENX US, INC.
$551
GENZYME CORPORATION
$540
Amgen Inc.
$531
Adamas Pharmaceuticals, Inc.
$520
Grifols USA, LLC
$469
Harmony Biosciences LLC
$429
Alexion Pharmaceuticals, Inc.
$409
SK Life Science, Inc.
$396
Acorda Therapeutics, Inc
$369
Neurelis, Inc.
$335
Amneal Pharmaceuticals LLC
$287
Jazz Pharmaceuticals Inc.
$262
Greenwich Biosciences, Inc.
$249
Boston Scientific Corporation
$247
Corium, LLC
$246
PFIZER INC.
$243
EISAI INC.
$241
Sumitomo Pharma America, Inc.
$239
Allergan Inc.
$220
BOSTON SCIENTIFIC CORPORATION
$214
Avadel CNS Pharmaceuticals, LLC
$205
HARMONY BIOSCIENCES LLC
$202
Mallinckrodt Hospital Products Inc.
$199
Mallinckrodt Enterprises LLC
$189
Kyowa Kirin, Inc.
$189
Biohaven Pharmaceuticals, Inc.
$178
Biohaven Pharmaceutical Holding Company Ltd.
$175
IMPEL PHARMACEUTICALS INC.
$170
Avanir Pharmaceuticals, Inc.
$136
AQUESTIVE THERAPEUTICS, INC.
$120
Supernus Pharmaceuticals, Inc.
$114
ARBOR PHARMACEUTICALS, INC.
$111
AbbVie, Inc.
$102
LivaNova USA, Inc.
$100
Axsome Therapeutics, Inc.
$92
Promius Pharma LLC
$90
GE HealthCare
$85
Vertical Pharmaceuticals, LLC
$78
Otsuka America Pharmaceutical, Inc.
$78
Avion Pharmaceuticals
$78
Upsher-Smith Laboratories LLC
$76
Merz North America, Inc.
$71
ASSERTIO THERAPEUTICS, Inc.
$70
Medtronic USA, Inc.
$69
Mallinckrodt LLC
$67
UPSHER-SMITH LABORATORIES LLC
$60
Horizon Therapeutics plc
$58
GE Healthcare
$57
SANOFI-AVENTIS U.S. LLC
$55
ANI Pharmaceuticals, Inc.
$48
Microtransponder, Inc.
$46
Aucta Pharmaceuticals, Inc.
$46
MDD US Operations, LLC
$42
IDORSIA PHARMACEUTICALS US INC
$39
Celgene Corporation
$34
InSightec,Inc
$33
Merck Sharp & Dohme Corporation
$33
Impax Laboratories, Inc.
$31
TerSera Therapeutics LLC
$29
Strongbridge US INC.
$28
Harmony Biosciences Llc
$26
BANNER LIFE SCIENCES, LLC
$24
Life Molecular Imaging Ltd
$22
Catalyst Pharmaceuticals, Inc.
$19
AstraZeneca Pharmaceuticals LP
$19
Almatica Pharma LLC
$17
Merck Sharp & Dohme LLC
$17
Currax Pharmaceuticals LLC
$16
Zyla Life Sciences, Inc.
$15
Zyla Life Sciences
$15
Azurity Pharmaceuticals, Inc.
$14
Zogenix Inc.
$13
Abbott Laboratories
$12
Piramal Imaging Limited
$10
Top 3 companies account for 42.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · Banzel · Briviact · COMIRNATY · COPAXONE · Cambia · DIVIGEL · DUOPA · Dayvigo · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Exablate · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMRYZ · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONZETRA XSAIL · ONZETRA Xsail · OSMOLEX ER · Ocrevus · Ongentys · PAXLOVID · PURIFIED CORTROPHIN GEL · Proclaim IPG · QULIPTA · QUVIVIQ · Qelbree · Quzyttir · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in TX.
Equivalent to $297 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
52
Per 100K population
7.9
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wang is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Wang performed 13,700 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $46,941 from 94 companies across 1,551 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other neurologys in Conroe?
Dr. Wang's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Conroe
Browse neurologys in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc..
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc..
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology